首页|期刊导航|iLABMED|Post-Translational Modifications of Key Proteins in Hematologic Malignancies:Carcinogenic Mechanisms,Biomarker Potential,and New Therapeutic Strategies

Post-Translational Modifications of Key Proteins in Hematologic Malignancies:Carcinogenic Mechanisms,Biomarker Potential,and New Therapeutic Strategies

Yuxuan Han Chaowei Zhang Weiyi Yao Qing Hong Xinyu Tang Yanan Zhu Na Chen

iLABMED2026，Vol.4Issue(2)：P.91-107,17.

iLABMED2026，Vol.4Issue(2)：P.91-107,17.DOI:10.1002/ila2.70064

Post-Translational Modifications of Key Proteins in Hematologic Malignancies:Carcinogenic Mechanisms,Biomarker Potential,and New Therapeutic Strategies

Yuxuan Han ¹Chaowei Zhang ¹Weiyi Yao ¹Qing Hong ¹Xinyu Tang ¹Yanan Zhu ¹Na Chen¹

作者信息

1. Department of Hematology,Beijing Luhe Hospital,Capital Medical University,Beijing,China Graduate School of Shandong First Medical University,Jinan,China
折叠

摘要

关键词

biomarker/early diagnosis/hematologic malignancy/post-translational modification/tumor development mechanism

分类

医药卫生

引用本文复制引用

Yuxuan Han,Chaowei Zhang,Weiyi Yao,Qing Hong,Xinyu Tang,Yanan Zhu,Na Chen..Post-Translational Modifications of Key Proteins in Hematologic Malignancies:Carcinogenic Mechanisms,Biomarker Potential,and New Therapeutic Strategies[J].iLABMED,2026,4(2):P.91-107,17.

基金项目

supported by the National Natural Science Foundation of China(Grant 62372276). （Grant 62372276）

iLABMED

ISSN：2834-443X

访问量0

下载量0

段落导航